New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS System for the Treatment of Patients with Obsessive Co false

בריינסוויי בע"מ	2 380
BRAINSWAY LTD
Corporation no: 513890764	10767

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	27/06/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-064942	Time of broadcast: 17:34 17:10:09

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

New Data Published in American Journal of Psychiatry Further Substantiates BrainsWay’s Deep TMS System for the Treatment of Patients with Obsessive Compulsive Disorder

Brainsway_6K_OCD_AJP_Publication_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: BWAY	Date of revision of form structure: 25/06/2019
Address: הרטום 19 , ירושלים 91451   , Tel: 02-5813140 , Fax: 02-5812517
E-mail address: uri@Brainsway.com   Company site: www.Brainsway.com
Previous names of reporting entity:
Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company:
Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: hadarl@brainsway.com 1